$RNAC
Cartesian Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000145368724000124 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $387.0K
YoY Change -94.09%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.562M
YoY Change -0.79%
% of Gross Profit
Research & Development $11.40M
YoY Change -12.32%
% of Gross Profit
Depreciation & Amortization $300.0K
YoY Change 200.0%
% of Gross Profit
Operating Expenses $17.96M
YoY Change -8.43%
Operating Profit -$17.58M
YoY Change 34.52%
Interest Expense $2.573M
YoY Change 102.12%
% of Operating Profit
Other Income/Expense, Net $250.0K
YoY Change -1.19%
Pretax Income -$24.18M
YoY Change 168.64%
Income Tax
% Of Pretax Income
Net Earnings -$24.18M
YoY Change 168.64%
Net Earnings / Revenue -6248.84%
Basic Earnings Per Share -$1.13
Diluted Earnings Per Share -$1.13
COMMON SHARES
Basic Shares Outstanding 25.41M shares 21.38M shares
Diluted Shares Outstanding 21.47M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $219.2M
YoY Change 175.36%
Cash & Equivalents $219.2M
Short-Term Investments
Other Short-Term Assets $4.129M
YoY Change 18.21%
Inventory
Prepaid Expenses
Receivables $4.829M
Other Receivables $980.0K
Total Short-Term Assets $229.1M
YoY Change 154.97%
LONG-TERM ASSETS
Property, Plant & Equipment $10.23M
YoY Change 322.35%
Goodwill $48.16M
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M
YoY Change 0.0%
Other Assets $1.669M
YoY Change 18.79%
Total Long-Term Assets $226.2M
YoY Change 1299.2%
TOTAL ASSETS
Total Short-Term Assets $229.1M
Total Long-Term Assets $226.2M
Total Assets $455.3M
YoY Change 329.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $517.0K
YoY Change 37.87%
Accrued Expenses $9.363M
YoY Change -31.34%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.41M
YoY Change 7.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $417.3M
YoY Change 1519.6%
Total Long-Term Liabilities $417.3M
YoY Change 1519.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.41M
Total Long-Term Liabilities $417.3M
Total Liabilities $454.6M
YoY Change 894.56%
SHAREHOLDERS EQUITY
Retained Earnings -$681.8M
YoY Change 56.02%
Common Stock $2.000K
YoY Change -86.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $752.0K
YoY Change
Total Liabilities & Shareholders Equity $455.3M
YoY Change 329.41%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$24.18M
YoY Change 168.64%
Depreciation, Depletion And Amortization $300.0K
YoY Change 200.0%
Cash From Operating Activities $13.69M
YoY Change -248.57%
INVESTING ACTIVITIES
Capital Expenditures $6.199M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$6.199M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 124.5M
YoY Change -602.21%
NET CHANGE
Cash From Operating Activities 13.69M
Cash From Investing Activities -6.199M
Cash From Financing Activities 124.5M
Net Change In Cash 132.0M
YoY Change -488.15%
FREE CASH FLOW
Cash From Operating Activities $13.69M
Capital Expenditures $6.199M
Free Cash Flow $7.492M
YoY Change -181.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9451625 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5397597 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-614647000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4600000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-440184000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
305050000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6551000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39111000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17738000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001453687
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Cartesian Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1622110
dei Entity Address Address Line1
EntityAddressAddressLine1
7495 New Horizon Way
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21703
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
348-8698
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
RNAC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219198000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76911000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4829000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5870000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
980000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2981000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4129000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4967000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
229136000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
90729000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10225000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2113000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13523000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10068000 usd
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
150600000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
150600000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
48163000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
48163000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1669000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1377000 usd
CY2023Q4 us-gaap Assets
Assets
305050000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
517000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3150000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
9452000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
15572000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2770000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2166000 usd
CY2024Q3 rnac Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
5000 usd
CY2023Q4 rnac Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
720000 usd
CY2024Q3 rnac Contingent Value Right Liability Current
ContingentValueRightLiabilityCurrent
8661000 usd
CY2023Q4 rnac Contingent Value Right Liability Current
ContingentValueRightLiabilityCurrent
15983000 usd
CY2024Q3 rnac Warrants And Rights Outstanding Noncurrent
WarrantsAndRightsOutstandingNoncurrent
3586000 usd
CY2023Q4 rnac Warrants And Rights Outstanding Noncurrent
WarrantsAndRightsOutstandingNoncurrent
5674000 usd
CY2024Q3 rnac Contingent Value Right Liability Noncurrent
ContingentValueRightLiabilityNoncurrent
401839000 usd
CY2023Q4 rnac Contingent Value Right Liability Noncurrent
ContingentValueRightLiabilityNoncurrent
342617000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15853000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15853000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
454564000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
444680000 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
296851000 usd
CY2024Q3 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2023Q4 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
3703000 usd
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25414898 shares
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000 usd
CY2024Q3 us-gaap Assets
Assets
455316000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2311000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
28307000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
21405000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68209000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11881000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8789000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3538000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
548375 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
435120.513 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5129030 shares
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Net Derivative Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#GainLossOnDerivativeInstrumentsNetPretax
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address City Or Town
EntityAddressCityOrTown
Frederick
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
435120.513 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9381617.247 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23896525 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23896525 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5397597 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
687174000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179062000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-681818000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4606000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
752000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
455316000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
387000 usd
CY2023Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
561000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2024Q3 us-gaap Revenues
Revenues
387000 usd
CY2023Q3 us-gaap Revenues
Revenues
6551000 usd
us-gaap Revenues
Revenues
39672000 usd
us-gaap Revenues
Revenues
17738000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11400000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13002000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33799000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49408000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6562000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6614000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23039000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18414000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
17962000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
19616000 usd
us-gaap Operating Expenses
OperatingExpenses
56838000 usd
us-gaap Operating Expenses
OperatingExpenses
67822000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17575000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13065000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17166000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-50084000 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
2573000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1299000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
4932000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
4024000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
39000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1273000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2833000 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5669000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3787000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2803000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6049000 usd
CY2024Q3 rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
15100000 usd
CY2023Q3 rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
51900000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
CY2024Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-6890000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
250000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
253000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1050000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
753000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-24183000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42052000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-69000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24198000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9022000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-67177000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42110000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-24183000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42052000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.20
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21471408 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21471408 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5160150 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5160150 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14561613 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14561613 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5129030 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
435120.513 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
296851000 usd
CY2023Q4 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
3703000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-440184000 usd
CY2024Q1 rnac Temporary Equity Stock Issued During Period Shares
TemporaryEquityStockIssuedDuringPeriodShares
99140.326 shares
CY2024Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
75197000 usd
CY2024Q1 rnac Temporary Equity Transfer Of Preferred Stock To Permanent Equity Shares
TemporaryEquityTransferOfPreferredStockToPermanentEquityShares
534260.839 shares
CY2024Q1 rnac Temporary Equity Transfer Of Preferred Stock To Permanent Equity
TemporaryEquityTransferOfPreferredStockToPermanentEquity
372048000 usd
CY2024Q1 rnac Temporary Equity Options Transfer Of Preferred Stock To Permanent Equity
TemporaryEquityOptionsTransferOfPreferredStockToPermanentEquity
3703000 usd
CY2024Q1 rnac Transfer Of Temporary Equity To Permanent Equity
TransferOfTemporaryEquityToPermanentEquity
375751000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
154000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2877000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1431000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-56824000 usd
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q1 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-116800000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
120000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
219000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1591000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
13836000 usd
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q2 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-101458000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
124657000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1695000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-24183000 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q3 rnac Temporary Equity Options Carrying Amount Attributable To Parent
TemporaryEquityOptionsCarryingAmountAttributableToParent
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
752000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
93828000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
149000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2276000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21663000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
74579000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2283000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11387000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65448000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
82000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1500000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2321000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9002000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
60329000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42052000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
665000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
571000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
79000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1766000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1278000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4717000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8380000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
455000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2803000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6049000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
51900000 usd
rnac Fair Value Adjustment Of Contingent Value Right Liability
FairValueAdjustmentOfContingentValueRightLiability
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-6890000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-740000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1041000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1698000 usd
rnac Increase Decrease In Contract With Customer Asset Allowance For Credit Loss Current
IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent
-2001000 usd
rnac Increase Decrease In Contract With Customer Asset Allowance For Credit Loss Current
IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent
-1287000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-763000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
30000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2690000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
36000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5849000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7528000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7904000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1638000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16672000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27875000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
28254000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8388000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
142000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8388000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28112000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27457000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2877000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
40000000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
124438000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
330000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
231000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
167645000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27226000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-69000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
142579000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27058000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78288000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108038000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220867000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80980000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
1853000 usd
rnac Stock Based Compensation Expense Incurred But Not Yet Paid
StockBasedCompensationExpenseIncurredButNotYetPaid
0 usd
rnac Stock Based Compensation Expense Incurred But Not Yet Paid
StockBasedCompensationExpenseIncurredButNotYetPaid
1500000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
392000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
65000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q3 rnac Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale
220900000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1700000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-681800000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-24183000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9002000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-42052000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21471408 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21471408 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5160150 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5160150 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14561613 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14561613 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5129030 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5129030 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.20
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9378000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1775411 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9378000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1775411 shares
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219198000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79603000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1669000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1377000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220867000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80980000 usd
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
148710.488 shares
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
28307000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
35197000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-6890000 usd
CY2024Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
0 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16538000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7841000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6313000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5728000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10225000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2113000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
300000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
100000 usd
us-gaap Depreciation
Depreciation
700000 usd
us-gaap Depreciation
Depreciation
500000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1778000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4390000 usd
CY2024Q3 rnac Accrued Patent Fees Current
AccruedPatentFeesCurrent
729000 usd
CY2023Q4 rnac Accrued Patent Fees Current
AccruedPatentFeesCurrent
472000 usd
CY2024Q3 rnac Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3943000 usd
CY2023Q4 rnac Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
4896000 usd
CY2024Q3 rnac Accrued Audit Fees Current
AccruedAuditFeesCurrent
2284000 usd
CY2023Q4 rnac Accrued Audit Fees Current
AccruedAuditFeesCurrent
4331000 usd
CY2024Q3 rnac Accrued Property Plant And Equipment Current
AccruedPropertyPlantAndEquipmentCurrent
339000 usd
CY2023Q4 rnac Accrued Property Plant And Equipment Current
AccruedPropertyPlantAndEquipmentCurrent
128000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
290000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
516000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9363000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14733000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1058000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
696000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2789000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2088000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
380000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
271000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1129000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
683000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
6000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
250000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
250000 usd
us-gaap Sublease Income
SubleaseIncome
1010000 usd
us-gaap Sublease Income
SubleaseIncome
756000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
1189000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
718000 usd
us-gaap Lease Cost
LeaseCost
2913000 usd
us-gaap Lease Cost
LeaseCost
2021000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
316000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4415000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4538000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4345000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2314000 usd
CY2024Q3 rnac Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3596000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19524000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4873000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14651000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2548000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1991000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.116
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.097
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
148710.488 shares
CY2023Q4 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
49570.162 shares
CY2024Q1 rnac Settlement Of Derivative Liability Shares
SettlementOfDerivativeLiabilityShares
49570.163 shares
CY2024Q1 rnac Number Of Business Days
NumberOfBusinessDays
8 business_day
CY2024Q2 rnac Convertible Preferred Stock Shares That Did Not Automatically Convert
ConvertiblePreferredStockSharesThatDidNotAutomaticallyConvert
166341.592 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1040813 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
45.98
rnac Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
65681 shares
rnac Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercises
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercises
43.80
rnac Stock Issued During Period Shares Warrants Canceled
StockIssuedDuringPeriodSharesWarrantsCanceled
178 shares
rnac Class Of Warrant Or Right Canceled Price Per Share
ClassOfWarrantOrRightCanceledPricePerShare
503.10
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
974954 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
46.04
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13215543 shares
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1695000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2321000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4717000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8380000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.89
CY2024Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
33.333
CY2024Q1 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
33.333
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q4 rnac Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
5849000 usd
rnac Contract With Customer Liability Deferred Revenue Increase From Cash Receipts
ContractWithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts
0 usd
rnac Contract With Customer Liability Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityDeferredRevenueRevenueRecognized
-5849000 usd
CY2024Q3 rnac Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
0 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5849000 usd
rnac Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
0 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-5849000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
rnac Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P2Y
CY2023Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
CY2024Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000 usd
us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.90
CY2023 us-gaap Restructuring Charges
RestructuringCharges
6400000 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
2500000 usd
us-gaap Restructuring Charges
RestructuringCharges
800000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
4600000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
3896000 usd
us-gaap Restructuring Charges
RestructuringCharges
777000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
4586000 usd
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
87000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001453687-24-000124-index-headers.html Edgar Link pending
0001453687-24-000124-index.html Edgar Link pending
0001453687-24-000124.txt Edgar Link pending
0001453687-24-000124-xbrl.zip Edgar Link pending
ex101secondamendmenttoleas.htm Edgar Link pending
exhibit311_9302024.htm Edgar Link pending
exhibit312_9302024.htm Edgar Link pending
exhibit321_9302024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rnac-20240930.htm Edgar Link pending
rnac-20240930.xsd Edgar Link pending
rnac-20240930_lab.xml Edgar Link unprocessable
rnac-20240930_htm.xml Edgar Link completed
Show.js Edgar Link pending
rnac-20240930_pre.xml Edgar Link unprocessable
rnac-20240930_def.xml Edgar Link unprocessable
rnac-20240930_cal.xml Edgar Link unprocessable